Cullinan Oncology LLC
Price & Volume
Stats
See more52W Range | $7.64-$30.18 |
Market Cap | $732.5M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $18.9M |
Diluted EPS | -$2.84 |
News
See moreYahoo Finance • 2 months ago
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Yahoo Finance • 11 months ago
Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Yahoo Finance • 11 months ago
Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-617, a Novel Fusion Protein Uniquely Harnessing Both IL-2 and IL-12 Cytokines
Yahoo Finance • last year
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
About
CEO | Mr. Nadim Ahmed |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 85 |
